Valeant Canada LP:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Valeant Canada LP - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10907
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical products manufacturing company. The company offers products such as aczone, airomir, aldara, benzaclin topical gel, benzamycin, biacna topical gel, C.E.S. tablets, carbolith, cardizem cd, cuprimine, dermatop cream, dermatop ointment, edecrin, efudex cream, elidel, etibi, glumetza, glycon, lodalis, loperacap, loprox cream, loprox lotion, mestinon tab, mestinon sr. It provides minitran, nidagel, nitoman, noritate, oxybutin, penlac, qvar, retin-a, retin-a micro, rofact, sodium edecrin, sulfacet r, theolair, tiazac, tiazac xc, topicort cream, topicort gel, topicort ointment, tryptan, ultravate, virazole, viroptic, vitamin a acid and vyloma, among others. Valeant Canada markets its products to pharmacies, healthcare practices and hospitals. The company operates manufacturing facilities in Manitoba, Ontario and Quebec. Valeant Canada is headquartered in Laval, Quebec, Canada.

Valeant Canada LP – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Valeant Canada LP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Valeant Canada LP, Medical Devices Deals, 2012 to YTD 2018 9
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Valeant Canada LP, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Valeant Canada Acquires Canadian Rights from Sanofi-aventis for Altace and Altace HCT 11
Valeant Canada Acquires Dermatology Products from Valeo Pharma for USD23 Million 12
Partnerships 13
Orexigen Therapeutics Enters Into Distribution Agreement With Valeant For Contrave 13
Licensing Agreements 14
Valeant Canada Enters into Licensing Agreement with Takeda Pharma for Edarbi and Edarbyclor 14
Acquisition 15
Valeant Canada Acquires CROMA Pharma Canada 15
Valeant Canada LP – Key Competitors 16
Valeant Canada LP – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Valeant Canada LP, Pharmaceuticals & Healthcare, Key Facts 2
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Valeant Canada LP, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Valeant Canada LP, Deals By Therapy Area, 2012 to YTD 2018 8
Valeant Canada LP, Medical Devices Deals, 2012 to YTD 2018 9
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Valeant Canada Acquires Canadian Rights from Sanofi-aventis for Altace and Altace HCT 11
Valeant Canada Acquires Dermatology Products from Valeo Pharma for USD23 Million 12
Orexigen Therapeutics Enters Into Distribution Agreement With Valeant For Contrave 13
Valeant Canada Enters into Licensing Agreement with Takeda Pharma for Edarbi and Edarbyclor 14
Valeant Canada Acquires CROMA Pharma Canada 15
Valeant Canada LP, Key Competitors 16
Valeant Canada LP, Other Locations 16

List of Figures
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Valeant Canada LP, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Valeant Canada LP, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Valeant Canada LP:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cardiff University-製薬・医療分野:企業M&A・提携分析
    Summary Cardiff University is an educational institute that provides educational and research services. The institute offers services such as undergraduate courses, post graduate courses, international courses, accommodations, and libraries, among others. It conducts research in the areas of enginee …
  • Saudi Industrial Investment Group (2250):企業の財務・戦略的SWOT分析
    Summary Saudi Industrial Investment Group (SIIG) is a petrochemical company that invests, improves and develops petrochemical industry. The company produces ethylene, polyethylene, hexene, polypropylene and polystyrene. It also provides benzene, propylene, cyclohexane, motor gasoline blend, and hydr …
  • Eni SpA (ENI):石油・ガス:M&Aディール及び事業提携情報
    Summary Eni SpA (Eni) is an integrated oil and gas company that carries out oil and natural gas exploration, field development and production activities. It is also involved in supply, trading and shipping of natural gas, LNG, electricity and fuels. The company has operations in Italy, Cyprus, the U …
  • GETECH Group plc (GTC):企業の財務・戦略的SWOT分析
    Summary Getech Group Plc (Getech) is an oil and gas service company that offers geological and geophysical services. The company’s services include regional reports, globe, commissions and global gravity and magnetic data solutions. Its in-house specialties comprise airborne geophysics, potential fi …
  • Bellway Plc (BWY):企業の財務・戦略的SWOT分析
    Bellway Plc (BWY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Dataprep Holdings Berhad (DATAPRP):企業の財務・戦略的SWOT分析
    Dataprep Holdings Berhad (DATAPRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • System Dynamics International Incorporated:企業の戦略・SWOT・財務分析
    System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report Summary System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Diamyd Medical AB (DMYD B):製薬・医療:M&Aディール及び事業提携情報
    Summary Diamyd Medical AB (Diamyd), formerly Diamyd Therapeutics AB is a drug development company that offers diabetes vaccine. The company's diabetes products include Diamyd, an antigen-based immunotherapy for the treatment of autoimmune diabetes. Its pipeline products include GAD, GABA, and other …
  • Ra Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ra Medical Systems Inc (Ra Medical Systems) is a medical device company that develops, designs, and commercializes excimer laser systems for the treatment of cardiovascular and dermatologic diseases. The company’s technology provides operational versatility and dose customization. Its produc …
  • Silvercorp Metals Inc.:企業の戦略・SWOT・財務情報
    Silvercorp Metals Inc. - Strategy, SWOT and Corporate Finance Report Summary Silvercorp Metals Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Swancor Holding Co Ltd (3708):企業の財務・戦略的SWOT分析
    Swancor Holding Co Ltd (3708) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Atlas Genetics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposab …
  • Shinsegae Inc (004170):企業の財務・戦略的SWOT分析
    Shinsegae Inc (004170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Advanced Info Service PLC (ADVANC):企業の財務・戦略的SWOT分析
    Advanced Info Service PLC (ADVANC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • BaxterStorey Ltd:企業の戦略・SWOT・財務分析
    BaxterStorey Ltd - Strategy, SWOT and Corporate Finance Report Summary BaxterStorey Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nordic Investment Bank:電力:M&Aディール及び事業提携情報
    Summary Nordic Investment Bank (NIB) is a banking and financial service provider that offers loans and capital market solutions. The company offers loan products such as project and structured loans, corporate loans, municipality’s loans, environmental loans, sovereign loans, and other loans. It als …
  • BYD Co Ltd (1211)-エネルギー分野:企業M&A・提携分析
    Summary BYD Company Limited (BYD) designs, manufactures and sells rechargeable batteries, photovoltaic products, handset components, and other electronic products. It also offers whole product assembly services to clients. As part of its automobile business, the company manufactures and offers tradi …
  • Nayara Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Nayara Energy Ltd (Nayara), formerly Essar Oil Ltd, a joint venture between Rosneft Oil Co, Trafigura Pte Ltd and UCP PE Investments Ltd, is a downstream company. It has presence in refining and marketing of oil refined products. The company operates a refinery at Vadinar in Gujarat, which i …
  • Network Rail Ltd:企業の戦略的SWOT分析
    Network Rail Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • BP Plc:企業のM&A・事業提携・投資動向
    BP Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BP Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆